Skip to main content Skip to main navigation menu Skip to site footer

Intractable singultus: a case report

Abstract

Background: Intractable singultus is a rare disorder, and there are no guidelines for its management. More than 100 etiologies are described in the literature, but the etiology cannot be defined in as much as 20% of patients. Acute singultus needs no further treatment, but intractable singultus warrants thorough evaluation and treatment because it has high morbidity and mortality.

Case Presentation: We present a 29-year-old male with intractable singultus accompanied by a sliding hiatal hernia, refractory to chlorpromazine and baclofen treatment, and hiatal hernia repair. The patient underwent hiatal hernia repair and Nissen fundoplication, which provided 3 days free of singultus. On the fourth postoperative day, the singultus begins 3 times a day, with episodes lasting up to 5 minutes, with a rate of 10-25 singultus per minute. The patient was discharged on postoperative day-5, hemodynamic was stable and no signs of infection were reported.

Conclusion: Symptomatic treatment for intractable singultusis often unsuccessful, with serious side effects that may impair the patient's quality of life. The cornerstone of the management of intractable singultus is finding the etiology.

 

References

  1. Hyun JJ, Bak YT. Clinical significance of hiatal hernia. Gut Liver. 2011;5(3):267-277.
  2. Steger M, Schneemann M, Fox M. Systemic review: the pathogenesis and pharmacological treatment of hiccups. Aliment Pharmacol Ther. 2015;42(9):1037-1050.
  3. Rouse S, Wodziak M. Intractable Hiccups. Curr Neurol Neurosci Rep. 2018;18(8):51.
  4. Polito NB, Fellows SE. Pharmacologic Interventions for Intractable and Persistent Hiccups: A Systematic Review. J Emerg Med. 2017;53(4):540-549.
  5. Laing TJ, Morariu MA, Malik GM, Patel SC. Intractable hiccups and a posterior fossa arteriovenous malformation: a case report. Henry Ford Hosp Med J. 1981;29(3):145-147.
  6. Lipsky MS. Chronic hiccups. Am Fam Physician. 1986;34(5):173-177.
  7. Souadjian JV, Cain JC. Intractable hiccup. Etiologic factors in 220 cases. Postgrad Med. 1968;43(2):72-77.
  8. LeWitt PA, Barton NW, Posner JB. Hiccup with dexamethasone therapy. Ann Neurol. 1982;12(4):405-406.
  9. Kevorkian M, Motte G, Kevorkian JP, Welti JJ. Hiccup and electroventricular stimulation with a pervenous electrode. Pacing Clin Electrophysiol. 1982;5(3):440-441.
  10. Eliraz A, Wishnitzer R, Mashiah A. Hiccup as a complication of displaced cardiac pacemaker electrode. Harefuah. 1981;100(7):335-336.
  11. Wilcox SK, Garry A, Johnson MJ. Novel use of amantadine: to treat hiccups. J Pain Symptom Manage. 2009;38(3):460-465.
  12. Porzio G, Aielli F, Verna L, Aloisi P, Galletti B, Ficorella C. Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience. Clin Neuropharmacol. 2010;33(4):179-180.
  13. Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract. J Gastroenterol Hepatol. 2009;24(4):537-546.
  14. Chou CL, Chen CA, Lin SH, Huang HH. Baclofen-induced neurotoxicity in chronic renal failure patients with intractable hiccups. South Med J. 2006;99(11):1308-1309.
  15. Landers C, Turner D, Makin C, Zaglul H, Brown R. Propofol associated hiccups and treatment with lidocaine. Anesth Analg. 2008;107(5):1757-1758.
  16. Becker DE. Nausea, vomiting, and hiccups: a review of mechanisms and treatment. Anesth Prog. 2010;57(4):150-157. doi:10.2344/0003-3006-57.4.150
  17. Lee AR, Cho YW, Lee JM, Shin YJ, Han IS, Lee HK. Treatment of persistent postoperative hiccups with stellate ganglion block: Three case reports. Medicine (Baltimore). 2018;97(48):e13370.

How to Cite

Hartono, A., & Lesmana, T. (2021). Intractable singultus: a case report. Bali Medical Journal, 10(3), 979–981. https://doi.org/10.15562/bmj.v10i3.2786

HTML
0

Total
0

Share

Search Panel